Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Teva halts output at U.S. drug plant after FDA flags concerns | SaltWire
FDA Warning Letter Reveals Data and Sterility Issues at Teva Plant in Hungary | RAPS
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | FiercePharma
Teva hopes to launch migraine drug as soon as September | Reuters
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. | FDA
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition | RAPS
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva Stops Production At US Plant After FDA Concerns: Report
Teva Pharmaceutical's AirDuo Digihaler gets FDA green light | MobiHealthNews
Teva wins FDA nod for sublingual film to treat opioid dependence - Drug Delivery Business
FDA accepts Teva-MedinCell's new drug application for schizophrenia drug
The Teva Advantage
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Celltrion FDA warning causes headache for Teva's biologics ambition
Jobs with Teva Pharmaceuticals, Inc.
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel
FDA's Call on Migraine Drug Could Be Trouble for Teva | Barron's
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Teva pulls over 2.5M vials of U.S. made drugs after FDA concerns on contamination | Seeking Alpha
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Teva secures FDA approval for Ajovy to prevent migraine episodes
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
